Two transfusion strategies for severe burn patients in non-shock stage: A comparative study
10.13303/j.cjbt.issn.1004-549x.2021.06.010
- VernacularTitle:重度烧伤患者非休克期2种输血治疗策略的比较
- Author:
Haiting YE
1
;
Jijun HU
1
;
Mei WANG
1
;
Ruolan LIU
1
Author Information
1. Department of Blood Transfusion, The Third Hospital of Wuhan, Wuhan 430000, China
- Publication Type:Journal Article
- Keywords:
burn;
restricted blood transfusion;
red blood cell;
treatment effect
- From:
Chinese Journal of Blood Transfusion
2021;34(6):607-609
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To investigate the effect of two different blood transfusion strategies in non-shock stage of sever burn patients, so as to provide reference for clinical rational use of blood. 【Methods】 74 cases of severe burn patients in our hospital from July 2019 to December 2020 were randomly divided into restrictive transfusion group and liberal transfusion group. The differences of blood transfusion volume, red blood cell (RBC) count before and after blood transfusion, Hb value, incidence of transfusion adverse reactions, postoperative infection rate, length of hospital stay, and 30 day mortality between the two groups were retrospectively analyzed. 【Results】 1) The blood transfusion volume of the restricted blood transfusion group [(9.58±7.43)U] was statistically less than that of the liberal blood transfusion group [(22.24±20.08)U] (P<0.05). 2) The increase of Hb per unit of RBC in the restrictive transfusion group [(4.98±3.37)g/L] was higher than that in the liberal transfusion group [(3.28±3.12)g/L], and the difference was statistically significant. (P< 0.05). 3) There were no significant differences in postoperative infection rate, incidence of transfusion adverse reaction, length of stay and 30 day mortality between the two groups (P> 0.05). 【Conclusion】 Limited blood transfusion treatment for severe burn patients in non-shock stage can reduce the frequency and risk of blood transfusion and save blood resources, which is of great significance for rational and safe blood use in clinic.
